Juvenal Tobin W, Castle Biosciences’ Chief Commercial Officer, sold 6,600 shares across two transactions priced from $32.32 to $35.14 per share. The transactions left him with 58,584 shares, a holding stated as about 10.1% of his prior shares, giving investors a specific view of the reported post-sale ownership.

Key Highlights

  • The transactions occurred on Sep 14 and Sep 15, 2026.
  • Both sales used transaction code S, which identifies open-market sales.
  • The post-transaction holding represented about 10.1% of Juvenal Tobin W’s prior shares holding.

CASTLE BIOSCIENCES INC (NASDAQ: CSTL) Chief Commercial Officer Juvenal Tobin W sold 6,600 shares across two transactions at prices ranging from $32.32 to $35.14 per share. The sales left him holding 58,584 shares.

The transactions were completed on Sep 14 and Sep 15, 2026. Both carried transaction code S, the classification used for open-market sales. The reported prices covered a range from $32.32 to $35.14 per share. Juvenal Tobin W was identified as Castle Biosciences’ Chief Commercial Officer.

Reported Holding After the Transactions

The stated post-transaction balance was 58,584 shares. That figure represented about 10.1% of Juvenal Tobin W’s prior shares holding. The reported percentage places the sale against his earlier ownership balance without changing the stated post-transaction share count.